Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents.

[1]  C. Rizzi.  Statistical Methods , 2020, Springer Theses.

[2]  X. Castellsagué.  Natural history and epidemiology of HPV infection and cervical cancer. , 2008, Gynecologic oncology.

[3]  M. Gottesman,et al.  SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism , 2008, Molecular Cancer Research.

[4]  J. Bernier,et al.  Docetaxel in the management of patients with head and neck squamous cell carcinoma , 2008, Expert review of anticancer therapy.

[5]  S. Park,et al.  Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.

[6]  M. Tahara.  [Recent advances in molecular-targeted drugs in head and neck cancer]. , 2008, Gan to kagaku ryoho. Cancer & chemotherapy.

[7]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[8]  N. D’Silva,et al.  Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. , 2006, Archives of otolaryngology--head & neck surgery.

[9]  N. D’Silva,et al.  Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. , 2006, Archives of otolaryngology--head & neck surgery.

[10]  Zhiwei Wang,et al.  IN VIVO MOLECULAR EVIDENCE OF CHEMOSENSITIZATION BY 3,3-DIINDOLYLMETHANE AGAINST PANCREATIC TUMOR , 2007 .

[11]  Jeremy MG Taylor,et al.  Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[12]  P. Altevogt,et al.  Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. , 2007, Cancer research.

[13]  Jake Yue Chen,et al.  A Systems Biology Approach to the Study of cisplatin Drug Resistance in Ovarian cancers , 2007, J. Bioinform. Comput. Biol..

[14]  Shadan Ali,et al.  Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. , 2006, Cancer research.

[15]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[16]  M. Abdelrahim,et al.  3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. , 2006, Carcinogenesis.

[17]  J. Savino,et al.  Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane , 2006, Molecular Cancer Therapeutics.

[18]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[19]  M. Abdelrahim,et al.  3 , 3 0-Diindolylmethane ( DIM ) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR 5 , 2006 .

[20]  D. Karunagaran,et al.  Biological and chemical inhibitors of NF‐κB sensitize SiHa cells to cisplatin‐induced apoptosis , 2005, Molecular carcinogenesis.

[21]  Shadan Ali,et al.  Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. , 2005, Cancer research.

[22]  J. Bourhis,et al.  Apport des méta-analyses sur données individuelles au traitement des cancers ORL , 2005 .

[23]  Yiwei Li,et al.  Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells. , 2005, Frontiers in bioscience : a journal and virtual library.

[24]  R. Bold,et al.  Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib , 2005, Cancer Chemotherapy and Pharmacology.

[25]  Shadan Ali,et al.  Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines. , 2004, Molecular cancer therapeutics.

[26]  Shadan Ali,et al.  Apoptosis-Inducing Effect of Chemotherapeutic Agents Is Potentiated by Soy Isoflavone Genistein, a Natural Inhibitor of NF-κB in BxPC-3 Pancreatic Cancer Cell Line , 2004, Pancreas.

[27]  Shishinn Sun,et al.  Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro , 2004, Cell stress & chaperones.

[28]  Yiwei Li,et al.  Mechanisms of Cancer Chemoprevention by Soy Isoflavone Genistein , 2004, Cancer and Metastasis Reviews.

[29]  R. Bold,et al.  AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2 , 2003, British Journal of Cancer.

[30]  F. Sarkar,et al.  Indole-3-Carbinol (I3C) Induces Apoptosis in Tumorigenic but Not in Nontumorigenic Breast Epithelial Cells , 2003, Nutrition and cancer.

[31]  J. Leahy,et al.  Characterization of a novel metabolic strategy used by drug‐resistant tumor cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  G. Firestone,et al.  3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. , 2002, Carcinogenesis.

[33]  Edward S. Kim,et al.  Novel therapeutics for head and neck cancer , 2002, Current opinion in oncology.

[34]  J. Ross,et al.  Dietary flavonoids: bioavailability, metabolic effects, and safety. , 2002, Annual review of nutrition.

[35]  J. Essigmann,et al.  Mechanisms of resistance to cisplatin. , 2001, Mutation research.

[36]  J. Pignon,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer , 2001 .

[37]  F. Sarkar,et al.  Translocation of Bax to mitochondria induces apoptotic cell death in Indole-3-carbinol (I3C) treated breast cancer cells , 2000, Oncogene.

[38]  E. Vokes,et al.  The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer. , 2000, Seminars in oncology.

[39]  E. Feuer,et al.  Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. , 2000, International journal of epidemiology.

[40]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[41]  R A Goldbohm,et al.  A review of mechanisms underlying anticarcinogenicity by brassica vegetables. , 1997, Chemico-biological interactions.

[42]  S. Beaudenon,et al.  Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39 , 1996, Journal of clinical microbiology.

[43]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[44]  W. Hong,et al.  Chemotherapy in head and neck cancer. , 1983, The New England journal of medicine.

[45]  Tannock If.  Chemotherapy for head and neck cancer. , 1984 .

[46]  M. al-Sarraf.  Chemotherapy strategies in squamous cell carcinoma of the head and neck. , 1984, Critical reviews in oncology/hematology.

[47]  J. Glick,et al.  Chemotherapy for squamous cell carcinoma of the head and neck: a progress report. , 1980, American journal of otolaryngology.